Purchase Agreements in the Pharmaceuticals Industry

1,634 Contracts & Agreements

Browse by Company

4Front Ventures Corp. (5 contracts)
60 DEGREES PHARMACEUTICALS, INC. (19)
Acacia Diversified Holdings, Inc. (6)
Acasti Pharma Inc. (1)
Accelerated Pharma, Inc. (11)
ACELRX PHARMACEUTICALS INC (11)
Acer Therapeutics Inc. (10)
Aclaris Therapeutics, Inc. (4)
Acreage Holdings, Inc. (1)
ACURA PHARMACEUTICALS, INC (1)
Adamis Pharmaceuticals Corp (18)
ADIAL PHARMACEUTICALS, INC. (12)
Aegerion Pharmaceuticals, Inc. (1)
AEOLUS PHARMACEUTICALS, INC. (8)
Aerpio Pharmaceuticals, Inc. (3)
AGILE THERAPEUTICS INC (6)
Akers Biosciences, Inc. (11)
AKESIS PHARMACEUTICALS, INC. (1)
Akorn (6)
Alexza Pharmaceuticals Inc. (2)
ALIMERA SCIENCES INC (9)
Allergan, plc (5)
ALSERES PHARMACEUTICALS INC (14)
Altus Pharmaceuticals Inc. (4)
Amag Pharmaceuticals (3)
Amneal Pharmaceuticals, Inc. (4)
Amphastar Pharma (3)
Ampio Pharmaceuticals, Inc. (10)
Anebulo Pharmaceuticals, Inc. (1)
ANGIOTECH PHARMACEUTICALS INC (1)
ANI Pharma Inc (12)
Anthera Pharmaceuticals Inc (5)
APP Pharmaceuticals, Inc. (2)
Applied BioSciences Corp. (2)
APRICUS BIOSCIENCES, INC. (28)
Aquestive Therapeutics, Inc. (5)
ARADIGM CORP (7)
Aralez Pharmaceuticals Inc. (22)
Arog Pharmaceuticals, Inc. (1)
ARTELO BIOSCIENCES, INC. (2)
Artemis Therapeutics, Inc. (6)
ARVINAS, INC. (1)
Assertio Holdings, Inc. (3)
Assertio Therapeutics, Inc (10)
Astex Pharmaceuticals, Inc (4)
AVADEL PHARMACEUTICALS PLC (5)
AVALON PHARMACEUTICALS INC (4)
AVANIR PHARMACEUTICALS, INC. (1)
AVENUE THERAPEUTICS, INC. (4)
AXIM BIOTECHNOLOGIES, INC. (6)
Axsome Therapeutics, Inc. (2)
AYTU BIOSCIENCE, INC (15)
BARR PHARMACEUTICALS INC (2)
Barrel Energy Inc. (1)
Baudax Bio, Inc. (12)
Bausch Health Companies Inc. (6)
Bespoke Extracts, Inc. (18)
Big Rock Partners Acquisition Corp. (10)
BIODELIVERY SCIENCES INTERNATIONAL INC (11)
Biofrontera Inc. (6)
BioPharmX Corp (10)
Biostar Pharmaceuticals, Inc. (2)
Blue Water Acquisition Corp. (2)
BODY & MIND INC. (13)
Boston Therapeutics, Inc. (12)
BRADLEY PHARMACEUTICALS INC (1)
Bright Green Corp (2)
Bristol-Myers Squibb (1)
CADENCE PHARMACEUTICALS INC (1)
CALLISTO PHARMACEUTICALS INC (3)
Canbiola, Inc. (18)
Cancer Prevention Pharmaceuticals, Inc. (1)
Cannabics Pharmaceuticals Inc. (4)
CANNAPHARMARX, INC. (11)
CANNAPOWDER, INC. (1)
Canopy Growth Corp (1)
Cantabio Pharmaceuticals Inc. (4)
Cara Therapeutics, Inc. (2)
CARDAX, INC. (5)
CASSAVA SCIENCES INC (4)
Catalent Inc (1)
Celator Pharmaceuticals Inc (1)
CELGENE CORP (1)
Cerecor Inc. (13)
CHINA PHARMA HOLDINGS, INC. (2)
Cingulate Inc. (7)
Citius Pharmaceuticals, Inc. (9)
Clearside Biomedical, Inc. (3)
CLS Holdings USA, Inc. (16)
CNS Pharmaceuticals, Inc. (7)
Cocrystal Pharma, Inc. (22)
COGNITION THERAPEUTICS INC (1)
COLLAGENEX PHARMACEUTICALS INC (1)
COLLEGIUM PHARMACEUTICAL, INC (1)
Context Therapeutics Inc. (2)
ContraVir Pharmaceuticals, Inc. (8)
Corcept Therapeutics Incorporated (3)
CorMedix Inc. (8)
COSMO VENTURES INC (5)
Cronos Group Inc. (1)
CUBIST PHARMACEUTICALS INC (1)
CUMBERLAND PHARMACEUTICALS INC (3)
Cure Pharmaceutical Holding Corp. (3)
Dermata Therapeutics, Inc. (4)
DURECT CORP (5)
DUSA PHARMACEUTICALS INC (1)
Egalet Corp (2)
Elanco Animal Health Inc (1)
ELITE PHARMACEUTICALS INC (12)
Eloxx Pharmaceuticals, Inc. (6)
ENCYSIVE PHARMACEUTICALS INC (2)
Endexx Corp (2)
Endo International plc (5)
Endo Pharmaceuticals Solutions Inc. (3)
EPIX Pharmaceuticals, Inc. (2)
Eton Pharmaceuticals, Inc. (7)
Evofem Biosciences, Inc. (23)
Evoke Pharma Inc (5)
Exactus, Inc. (10)
EYEGATE PHARMACEUTICALS INC (11)
EYENOVIA, INC. (5)
EyePoint Pharmaceuticals, Inc. (3)
Foamix Pharmaceuticals Ltd. (1)
FRONTIER OILFIELD SERVICES INC (1)
Fulcrum Therapeutics, Inc. (1)
Furiex Pharmaceuticals, Inc. (1)
Gala Pharmaceutical Inc. (1)
GB SCIENCES INC (8)
GRAYBUG VISION, INC. (2)
GREEN HYGIENICS HOLDINGS INC. (6)
GridIron BioNutrients, Inc. (9)
GUILFORD PHARMACEUTICALS INC (1)
HARROW HEALTH, INC. (17)
Haymaker Acquisition Corp. III (3)
Horizon Pharma plc (4)
Hoth Therapeutics, Inc. (9)
IMAGING3 INC (1)
IMARA Inc. (3)
INNOVATE BIOPHARMACEUTICALS, INC. (9)
Innoviva, Inc. (2)
IntelGenx Technologies Corp. (10)
Intersect ENT, Inc. (1)
ISTA PHARMACEUTICALS INC (4)
Item 9 Labs Corp. (5)
Iterum Therapeutics plc (10)
Jaguar Health, Inc. (27)
Jazz Pharmaceuticals plc (5)
Jiangbo Pharmaceuticals, Inc. (2)
Journey Medical Corp (6)
JUNIPER PHARMACEUTICALS INC (7)
Jushi Holdings Inc. (1)
Kala Pharmaceuticals, Inc. (4)
Kannalife Inc (5)
Kedem Pharmaceuticals Inc. (1)
KEMPHARM, INC (5)
KING PHARMACEUTICALS INC (3)
KOS PHARMACEUTICALS INC (1)
Landos Biopharma, Inc. (1)
Lannett Company, Inc. (1)
Lev Pharmaceuticals Inc (3)
Level Brands, Inc. (3)
Lexaria Bioscience Corp. (13)
LIPELLA PHARMACEUTICALS INC (1)
Lipocine Inc. (3)
Liquidia Corp (1)
Longboard Pharmaceuticals, Inc. (1)
Lowell Farms Inc. (2)
Luckwel Pharmaceuticals Inc. (1)
Lyra Therapeutics, Inc. (2)
Mallinckrodt (6)
Marijuana Co of America, Inc. (2)
MARINUS PHARMACEUTICALS INC (2)
MedGen, Inc. (1)
Medicine Man Technologies, Inc. (41)
MedMen Enterprises, Inc. (4)
Melt Pharmaceuticals, Inc. (1)
MEMORY PHARMACEUTICALS CORP (1)
Menlo Therapeutics Inc. (5)
MICROCHANNEL TECHNOLOGIES CORP (5)
MiddleBrook Pharmaceuticals, Inc. (7)
Milestone Pharmaceuticals Inc. (3)
Mind Medicine (MindMed) Inc. (1)
MJ Holdings, Inc. (10)
Molecular Insight Pharmaceuticals, Inc. (2)
Mylan N.V. (2)
MYnd Analytics, Inc. (5)
Nabriva Therapeutics plc (6)
NEKTAR THERAPEUTICS (5)
Neuralstem, Inc. (13)
NEW RIVER PHARMACEUTICALS INC (1)
NewBridge Global Ventures, Inc. (10)
NEXIEN BIOPHARMA, INC. (1)
Notis Global, Inc. (28)
NovaBay Pharmaceuticals, Inc. (16)
Novan, Inc. (10)
NOVEN PHARMACEUTICALS INC (1)
NPS PHARMACEUTICALS INC (6)
NURX PHARMACEUTICALS, INC. (1)
OCULAR THERAPEUTIX, INC (1)
OMEROS CORP (3)
OncoMed Pharmaceuticals Inc (1)
Onconova Therapeutics, Inc. (12)
One World Pharma, Inc. (8)
OPIANT PHARMACEUTICALS, INC. (2)
ORAMED PHARMACEUTICALS INC. (12)
OSCIENT PHARMACEUTICALS CORP (2)
Osmotica Pharmaceuticals plc (2)
Panacea Acquisition Corp (6)
PANACOS PHARMACEUTICALS, INC. (1)
Paratek Pharmaceuticals, Inc. (2)
PaxMedica, Inc. (3)
PENWEST PHARMACEUTICALS CO (1)
PetLife Pharmaceuticals, Inc. (2)
Petros Pharmaceuticals, Inc. (4)
Pharmagreen Biotech Inc. (4)
PHARMOS CORP (2)
Phibro Animal Health Corporation (4)
Planet 13 Holdings Inc. (4)
PLAYERS NETWORK (22)
PLx Pharma Inc. (13)
POLYDEX PHARMACEUTICALS LTD (1)
PONIARD PHARMACEUTICALS, INC. (2)
PRAECIS PHARMACEUTICALS INC (1)
Prestige Brands Holdings Inc (4)
PRESTWICK PHARMACEUTICALS INC (1)
Processa Pharmaceuticals, Inc. (9)
ProPhase Labs, Inc. (3)
PROVECTUS BIOPHARMACEUTICALS, INC. (3)
Provention Bio, Inc. (7)
Pulmatrix, Inc. (11)
QUANTA INC (4)
QUESTCOR PHARMACEUTICALS INC (3)
Quoin Pharmaceuticals, Ltd. (6)
RADIENT PHARMACEUTICALS Corp (1)
Recro Pharma, Inc. (6)
Reliant Pharmaceuticals, Inc. (1)
RELMADA THERAPEUTICS, INC. (5)
RespireRx Pharmaceuticals Inc. (24)
ROCK CREEK PHARMACEUTICALS, INC. (4)
Roivant Sciences Ltd. (4)
Royalty Pharma plc (5)
Sagent Pharmaceuticals, Inc. (3)
SALIX PHARMACEUTICALS LTD (2)
Satsuma Pharmaceuticals, Inc. (1)
SAVIENT PHARMACEUTICALS INC (1)
SCICLONE PHARMACEUTICALS INC (2)
Scopus BioPharma Inc. (3)
SCYNEXIS INC (1)
SenesTech, Inc. (11)
SIGA TECHNOLOGIES INC (2)
Sonoma Pharmaceuticals, Inc. (17)
Stem Holdings, Inc. (1)
Sucampo Pharmaceuticals, Inc. (3)
Sunset Island Group (2)
SUNWIN STEVIA INTERNATIONAL, INC. (1)
Supernus Pharmaceuticals, Inc. (8)
SYNERGY PHARMACEUTICALS, INC. (12)
Synovics Pharmaceuticals (1)
TAPESTRY PHARMACEUTICALS, INC (1)
Target Group Inc. (10)
Targeted Medical Pharma, Inc. (4)
TAURIGA SCIENCES, INC. (40)
Tenzing Acquisition Corp. (7)
Terra Tech Corp. (33)
TerrAscend Corp. (3)
TETRALOGIC PHARMACEUTICALS CORP (2)
TETRAPHASE PHARMACEUTICALS INC (3)
Textmunication Holdings, Inc. (13)
TFF Pharmaceuticals, Inc. (4)
The Medicines Company (1)
TherapeuticsMD, Inc. (1)
Theravance Biopharma, Inc. (2)
Tilray, Inc. (2)
TILT Holdings Inc. (1)
TITAN PHARMACEUTICALS INC (13)
Tribute Pharmaceuticals Canada Inc. (7)
Tricida, Inc. (1)
Upjohn Inc (1)
Urigen Pharmaceuticals, Inc. (3)
Urovant Sciences Ltd. (1)
VALEANT PHARMACEUTICALS INTERNATIONAL (1)
Valera Pharmaceuticals Inc (1)
Vallon Pharmaceuticals, Inc. (7)
VASO ACTIVE PHARMACEUTICALS INC (1)
Ventyx Biosciences, Inc. (1)
VIA Pharmaceuticals, Inc. (3)
Virpax Pharmaceuticals, Inc. (1)
Vitality Biopharma, Inc. (18)
VIVUS INC (7)
WEED, INC. (3)
XANODYNE PHARMACEUTICALS INC (1)
Xeris Biopharma Holdings, Inc. (1)
XERIS PHARMACEUTICALS INC (1)
ZOGENIX, INC. (6)
Zomedica Pharmaceuticals Corp. (7)
Zynerba Pharmaceuticals, Inc. (1)

Recent Contracts

Form of Securities Purchase Agreement to be entered into in this Offering (Virpax Pharmaceuticals, Inc., Filed With SEC on April 18, 2024)
Purchase and Sale Agreement, dated as of April 14, 2024, by and among Endo International plc, the Sellers defined therein and the Buyers defined therein (Endo International plc, Filed With SEC on April 18, 2024)
Form of Securities Purchase Agreement, dated April 8, 2024 (EYENOVIA, INC., Filed With SEC on April 9, 2024)
Asset Purchase Agreement dated as of September 26, 2023 (Exactus, Inc., Filed With SEC on April 1, 2024)
Amended and Restated Royalty Purchase Agreement between Omeros Corporation and DRI Healthcare Acquisitions LP dated February 1, 2024 (OMEROS CORP, Filed With SEC on April 1, 2024)
Securities Purchase Agreement, dated March (Cerecor Inc., Filed With SEC on March 28, 2024)
Securities Purchase Agreement, dated March 25, 2024, by and among KALA BIO, Inc. and the purchasers party thereto (Kala Pharmaceuticals, Inc., Filed With SEC on March 26, 2024)
Form of Securities Purchase Agreement, dated as of March 20, 2024 (TFF Pharmaceuticals, Inc., Filed With SEC on March 22, 2024)
Securities Purchase Agreement, dated March 14, 2024 (Textmunication Holdings, Inc., Filed With SEC on March 20, 2024)
Securities Purchase Agreement, dated March 19, 2024, by and among the Company and the Purchasers named therein (IMARA Inc., Filed With SEC on March 19, 2024)
WARRANTS TO PURCHASE SERIES C PREFERRED SHARES OF TERRASCEND CORP. (TerrAscend Corp., Filed With SEC on March 14, 2024)
WARRANTS TO PURCHASE UP TO 33,440 COMMON SHARES OF TerrAscend Corp. (existing under the laws of Ontario) Void After ___________, 2024 (TerrAscend Corp., Filed With SEC on March 14, 2024)
Membership Unit Purchase Agreement, dated March 12, 2024, by and among the Company, DERMAdoctor, and the Buyer (NovaBay Pharmaceuticals, Inc., Filed With SEC on March 14, 2024)
Form of Securities Purchase Agreement, dated as of March 7, 2024 between Mind Medicine (MindMed) Inc. and the Investors (Mind Medicine (MindMed) Inc., Filed With SEC on March 11, 2024)
Securities Purchase Agreement (Quoin Pharmaceuticals, Ltd., Filed With SEC on March 8, 2024)
Form of Amendment to Warrants to Purchase Ordinary Shares Represented by American Depositary Shares (Quoin Pharmaceuticals, Ltd., Filed With SEC on March 8, 2024)
Purchase and Sale Agreement dated November 1, 2023 by and between Cara Royalty Sub, LLC and HCRX Investments Holdco, L.P. and Healthcare Royalty Partners IV, L.P (Cara Therapeutics, Inc., Filed With SEC on March 6, 2024)
Securities Purchase Agreement, dated March 4, 2024, by and between Nektar Therapeutics and TCG Crossover Fund II, L.P (NEKTAR THERAPEUTICS, Filed With SEC on March 4, 2024)
Amendment to Purchase and Sale Agreement between ANI Pharmaceuticals Canada Inc. and Mastercom Inc (ANI Pharma Inc, Filed With SEC on February 29, 2024)
Purchase and Sale Agreement between ANI Pharmaceuticals Canada Inc. and Mastercom Inc (ANI Pharma Inc, Filed With SEC on February 29, 2024)
Form of Securities Purchase Agreement, dated February 19, 2024, by and amount Biofrontera Inc. and the purchasers named therein (Biofrontera Inc., Filed With SEC on February 23, 2024)
Agreement of Purchase and Sale between ANI Pharmaceuticals Canada, Inc. and 1540700 Ontario Limited (ANI Pharma Inc, Filed With SEC on February 23, 2024)
Securities Purchase Agreement, dated February 21, 2024, by and among the Company and the other parties thereto (OCULAR THERAPEUTIX, INC, Filed With SEC on February 22, 2024)
Form of Purchase Agreement (Bespoke Extracts, Inc., Filed With SEC on February 20, 2024)
Form of Securities Purchase Agreement (Lexaria Bioscience Corp., Filed With SEC on February 16, 2024)
Form of Securities Purchase Agreement (Quoin Pharmaceuticals, Ltd., Filed With SEC on February 13, 2024)
Form of Securities Purchase Agreement, dated February 6, 2024 by and among Clearside Biomedical, Inc. and the purchasers party thereto (Clearside Biomedical, Inc., Filed With SEC on February 8, 2024)
Form of Securities Purchase Agreement (Cingulate Inc., Filed With SEC on February 7, 2024)
Membership Interest Purchase Agreement by and between Vegas Brazil LLC, Nevada Medical Group, LLC and DEP Nevada, Inc., dated January 31, 2024 (BODY & MIND INC., Filed With SEC on February 6, 2024)
Asset Purchase Agreement by and between Elanco Animal Health Incorporated as Seller and Intervet International as Buyer dated as of February 5, 2024 (Elanco Animal Health Inc, Filed With SEC on February 5, 2024)
Asset Purchase Agreement dated January 29, 2024, by and between the Issuer and PLM Holdings, Inc (Exactus, Inc., Filed With SEC on February 5, 2024)
Asset Purchase Agreement dated September 26, 2023, by and between the Issuer and PUR Life Medical, Inc (Exactus, Inc., Filed With SEC on February 5, 2024)
Form of Securities Purchase Agreement, dated as of February 1, 2024, between GRI Bio, Inc. and each purchaser named in the signature pages thereto (Vallon Pharmaceuticals, Inc., Filed With SEC on February 2, 2024)
Form of Securities Purchase Agreement (CNS Pharmaceuticals, Inc., Filed With SEC on February 2, 2024)
Securities Purchase Agreement, dated as of January 30, 2024, by and between cbdMD, Inc. and the Investors (Level Brands, Inc., Filed With SEC on February 2, 2024)
Form of Securities Purchase Agreement (Vallon Pharmaceuticals, Inc., Filed With SEC on January 31, 2024)
Purchase Agreement between the Company and Alumni Capital LP dated January 25, 2024 (Quoin Pharmaceuticals, Ltd., Filed With SEC on January 30, 2024)
Form of Securities Purchase Agreement, dated January 26, 2024, by and between Processa Pharmaceuticals, Inc. and each of the Purchasers (as defined therein) (Processa Pharmaceuticals, Inc., Filed With SEC on January 30, 2024)
Form of Securities Purchase Agreement, dated January 26, 2024 (APRICUS BIOSCIENCES, INC., Filed With SEC on January 30, 2024)
Form of Securities Purchase Agreement (Cingulate Inc., Filed With SEC on January 29, 2024)